3'-deamino-3'-hydroxydoxorubicin

Known as: 3-DHD, 5,12-Naphthacenedione, 10-((2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-, hydroxyrubicin 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2014
012319842014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Cells that acquire multidrug resistance (MDR) are characterized by a decreased accumulation of a variety of drugs. In addition… (More)
Is this relevant?
2000
2000
Multidrug resistance phenotype in mammalian cells is often correlated with overexpression of P-glycoprotein or Multidrug… (More)
Is this relevant?
1997
1997
The knowledge about molecular factors driving simple ligand-DNA interactions is still limited. The aim of the present study was… (More)
Is this relevant?
1994
1994
Previous studies have revealed that cultured cells treated with lipophilic natural products containing aromatic rings and basic… (More)
Is this relevant?
1994
1994
In vivo effectiveness of doxorubicin remains restricted due to toxicity and drug resistance. Hydroxyrubicin is a synthetic analog… (More)
Is this relevant?
1994
1994
Hydroxyrubin (OH-Dox), a neutral doxorubicin derivative that is only slightly cross-resistant to doxorubicin (Dox), can be… (More)
Is this relevant?
1993
1993
Hydroxyrubicin, a synthetic doxorubicin analog in which the basic amino group at C-3' is replaced by a hydroxyl group, was used… (More)
Is this relevant?
1993
1993
N-Benzyladriamycin-14-valerate (AD 198)-resistant murine J774.2 macrophage-like cells (A300) exhibited a novel mechanism of… (More)
Is this relevant?
1993
1993
Results presented in this study indicate that monensin, a Na+/H+ gradient ionophore, is by itself a potent inhibitor of… (More)
Is this relevant?
1984
1984
Two successful routes have been developed for preparation of 3'-deamino-3'-hydroxydoxorubicin (11), based on protection of the 14… (More)
  • table 1
Is this relevant?